February 4, 2022
A team of engineers and veterinarians at Purdue University in the US has embedded horse slickers with nanomaterials to gauge whether these fabrics can monitor the animal’s health.
February 4, 2022
A first-of-its-kind horse slicker with a specially designed liner could be able to tell the horse’s human caregivers of increasing chronic diseases.
February 3, 2022
Researcher says quickly determining if an animal has bovine respiratory disease may prevent unnecessary antibiotic use.
February 2, 2022
Co-primary investigators Knapp and Mohammadi received $44,656 for "Detecting Transitional Cell Carcinoma and Leptospirosis in Urine." The innovation has been licensed from the Office of Technology Commercialization to Molecular Diagnostics, a startup company. The project focuses on creating a fast, noninvasive and low-cost cancer screening technique. The initial focus is detecting bladder cancer in dogs, but the eventual goal is detecting bladder cancer and other disease in people.
January 26, 2022
At their final meeting of 2021, the Board of Trustees ratified six new named and distinguished professors.
January 21, 2022
Satellite cells differentiate into muscle cells or self-renew depending on the level of lipid droplets in the cell. Shihuan Kuang, a Purdue University professor of animal sciences, showed for the first time that fat inside adult muscle stem cells regulates their fate.
January 18, 2022
Medicinal chemistry researchers at Purdue University are further developing a potential immunotherapy treatment for cancer; this one focused on the particular mutation of an enzyme. "While recent progress in cancer immunotherapy has led to revolutionary success in multiple cancer types, most cancer patients do not benefit from immunotherapy," Zhong-Yin Zhang, head of the Department of Medicinal Chemistry and Molecular Pharmacology, and director of the Purdue Institute for Drug Discovery, said in a release. "Thus, there is an urgent need for additional strategies."
Purdue researchers take successful steps in potential cancer treatment
January 18, 2022
As science struggles to contain the latest strain of COVID-19, the Omicron variant, experts are keeping a wary eye on what might come next.
January 14, 2022
The unprecedented rise in COVID-19 positivity surrounding campus has created uncertainty for students and professors alike and may lead more professors to move their classes online for the time being.
Read More about "Classes march on as COVID positivity remains high"
January 14, 2022
“This past year has been very exciting for the Improved Pharma team,” exclaims Dr. Stephen Byrn, CSO of Improved Pharma. “We’re grateful to our collaborators for all they are doing to advance pharmaceutical development and are thrilled to be a part of these very important studies.”
Improved Pharma Announces Pharmaceutical R&D Efforts in 2021
